From 414b50b4932b2b09364c59cc65a9990e8b9e3395 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 19 Feb 2024 15:52:57 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web.md b/pages/STOP2030___Web.md index 9831eec1..2adeab65 100644 --- a/pages/STOP2030___Web.md +++ b/pages/STOP2030___Web.md @@ -48,5 +48,5 @@ This [[project]], [[STOP2030]], seeks to complement the results of the safety and efficacy trial with a field-based safety and effectiveness clinical study, acceptability studies in [[Ghana]] and [[Kenya]], modelling and cost-effectiveness exercises. The resulting information will be consolidated to build a multidisciplinary package for policy making and [[WHO]] guidance with the support of advocacy and communication activities to reach stakeholders and maximize the exploitation and impact of the [[FDC]] for [[STH]] control and elimination. The Consortium assembled to execute the [[STOP2030]] proposal combines expertise in complementary fields [[from]] program assessment and implementation through Ministries of [[Health]] in sub Saharan African countries, advocacy, state of the art technology, leadership in clinical research and a pharma that has shown commitment for generating access to drugs against NTDs and has recently obtained [[WHO]] prequalification for generic ivermectin #INFO - - Project duration (36 months); cuando empieza y cuando acaba (20 junio 2026) + - [[Project]] [[duration]] (36 months); cuando empieza y cuando acaba (20 junio 2026) - \ No newline at end of file